Atherosclerosis remains a major public health problem in Western-style societies, with rapidly increasing incidence worldwide. Monocyte-derived macrophages (MPs) and vascular smooth muscle cell (VSMCs) participate in early fatty streak formation, intermediate plaque progression, and importantly, in advanced plaque necrotic core expansion and fibrous cap thinning that determine the likelihood of plaque rupture, the most frequent proximal cause of clinical events such as unstable angina, myocardial infarction, or stroke. Interventions that decrease pro-inflammatory activities, prevent VSMC demise, and promote macrophage clearance function could break the cycle of cell recruitment, death, and corpse accumulation that drives necrotic core expansion and plaque instability. To promote the development of novel therapeutic strategies that mediate such desirable activities, this project seeks to understand molecular mechanisms controlling MP and VSMC activities that contribute to vulnerable plaque formation and rupture. The focus of these studies is a protein called allograft inflammatory factor-1 (Aif-1), also known as Ionized binding adapter-1 (Iba1), which was initially characterized as a cytoplasmic MP protein involved directly in phagocytosis and actin bundling. Aif-1 lacks a classical secretory signal, but recent reports suggest that Aif-1 has activities as a soluble factor outside the cell, including pro-inflammatory effects. We hypothesize that EC and IC Aif-1 mediate distinct cellular functions, and that the ability to manipulate these functions separately may have therapeutic value - selective blockade of EC Aif-1 without affecting IC Aif-1 could limit inflammatory cytokine production, while preserving the phagocytic activities that enable MPs to clear cellular debris that results from inflammation and cell death. We propose three aims, in which we will compare how IC and EC Aif-1 differentially affect MP and VSMC activities, test the relative importance of MP and VSMC Aif-1 in in vivo mouse models of vascular remodeling and atherogenesis, and determine whether inhibition of EC Aif-1 without limiting IC Aif-1 can reverse the processes that promote necrotic core expansion and plaque destabilization. We anticipate that these studies will provide molecular insight into Aif-1 function and test its viability as a potential therapeutic target in strategies to decrease plaque rupture.

Public Health Relevance

Atherosclerosis is the leading cause of death and disability in Western-style societies, with rapidly increasing incidence worldwide. The most serious consequences of atherosclerosis are caused by blood clots that form at sites of partial arterial narrowing called plaques. These plaques, which contain deposits of excess cholesterol and dead cells, expand and weaken the lining of the arterial wall; with progressive weakening, the plaques can rupture, and these sudden rupture events cause local clot formation, which can completely occlude the artery and block blood flow to vital organs. The goal of this project is to find new ways to prevent plaque expansion and weakening, and so to decrease the catastrophic end results of atherosclerosis, including unstable angina, myocardial infarction, and stroke.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Olive, Michelle
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Albert Einstein College of Medicine, Inc
United States
Zip Code
Riascos-Bernal, Dario F; Sibinga, Nicholas E S; Kitsis, Richard N (2018) PDCD5 says no to NO. Proc Natl Acad Sci U S A 115:4535-4537
Peters, Lauren A; Perrigoue, Jacqueline; Mortha, Arthur et al. (2017) A functional genomics predictive network model identifies regulators of inflammatory bowel disease. Nat Genet 49:1437-1449
Rowley, Anne H; Baker, Susan C; Kim, Kwang-Youn A et al. (2017) Allograft Inflammatory Factor-1 Links T-Cell Activation, Interferon Response, and Macrophage Activation in Chronic Kawasaki Disease Arteritis. J Pediatric Infect Dis Soc 6:e94-e102
Wang, Yidong; Wu, Bingruo; Lu, Pengfei et al. (2017) Uncontrolled angiogenic precursor expansion causes coronary artery anomalies in mice lacking Pofut1. Nat Commun 8:578